Dentsply Sirona Retains Wellspect Healthcare After Strategic Review, Ends Sale Process

DENTSPLY SIRONA Inc.

Strategic review of Wellspect begun Feb 2025 completed Sep 8, 2025; company decided to retain the business.
Wellspect is a leader in continence care with LoFric and Navina brands; mid-single digit organic sales growth in 2024.
CEO Dan Scavilla cited strong cash flow, untapped market potential, and a $2B addressable market for the decision.
Company conducted broad outreach and considered a sale but determined retention creates more stockholder value.

item 7.01item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.